Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4153.74 | 2642 / 2642 | 100% | 87.97 | 705 / 705 |
esophagus | 100% | 3433.83 | 1445 / 1445 | 100% | 49.35 | 183 / 183 |
lung | 100% | 3240.49 | 578 / 578 | 100% | 73.12 | 1155 / 1155 |
ovary | 100% | 3414.67 | 180 / 180 | 100% | 50.13 | 430 / 430 |
uterus | 100% | 3491.51 | 170 / 170 | 100% | 75.97 | 459 / 459 |
breast | 100% | 3774.91 | 459 / 459 | 100% | 75.19 | 1117 / 1118 |
thymus | 100% | 3678.78 | 653 / 653 | 100% | 60.16 | 604 / 605 |
bladder | 100% | 4306.33 | 21 / 21 | 100% | 63.64 | 503 / 504 |
stomach | 100% | 2833.91 | 359 / 359 | 100% | 50.33 | 285 / 286 |
prostate | 100% | 3520.65 | 245 / 245 | 100% | 57.23 | 500 / 502 |
kidney | 100% | 3373.87 | 89 / 89 | 99% | 40.09 | 895 / 901 |
intestine | 100% | 3967.03 | 966 / 966 | 99% | 59.19 | 523 / 527 |
skin | 100% | 3957.95 | 1809 / 1809 | 99% | 64.28 | 466 / 472 |
pancreas | 99% | 1789.99 | 326 / 328 | 99% | 47.65 | 176 / 178 |
adrenal gland | 100% | 4322.69 | 258 / 258 | 97% | 33.07 | 223 / 230 |
liver | 100% | 1656.04 | 226 / 226 | 94% | 25.45 | 380 / 406 |
adipose | 100% | 3904.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3192.93 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 79.14 | 29 / 29 |
spleen | 100% | 3893.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 68.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.98 | 1 / 1 |
muscle | 100% | 2634.55 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2092.09 | 839 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 30.85 | 75 / 80 |
peripheral blood | 69% | 2355.99 | 645 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046833 | Biological process | positive regulation of RNA export from nucleus |
GO_0006408 | Biological process | snRNA export from nucleus |
GO_0031053 | Biological process | primary miRNA processing |
GO_0031124 | Biological process | mRNA 3'-end processing |
GO_0031442 | Biological process | positive regulation of mRNA 3'-end processing |
GO_0008334 | Biological process | histone mRNA metabolic process |
GO_0000184 | Biological process | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0032968 | Biological process | positive regulation of transcription elongation by RNA polymerase II |
GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0006406 | Biological process | mRNA export from nucleus |
GO_0035195 | Biological process | miRNA-mediated post-transcriptional gene silencing |
GO_0016071 | Biological process | mRNA metabolic process |
GO_0008380 | Biological process | RNA splicing |
GO_0035194 | Biological process | regulatory ncRNA-mediated post-transcriptional gene silencing |
GO_0006446 | Biological process | regulation of translational initiation |
GO_0002191 | Biological process | cap-dependent translational initiation |
GO_0045292 | Biological process | mRNA cis splicing, via spliceosome |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0005846 | Cellular component | nuclear cap binding complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0034518 | Cellular component | RNA cap binding complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000339 | Molecular function | RNA cap binding |
GO_0017069 | Molecular function | snRNA binding |
GO_0000340 | Molecular function | RNA 7-methylguanosine cap binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NCBP2 |
Protein name | Nuclear cap binding protein subunit 2 Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (Cell proliferation-inducing gene 55 protein) (NCBP 20 kDa subunit) (CBP20) (NCBP-interacting protein 1) (NIP1) |
Synonyms | hCG_40296 PIG55 CBP20 |
Description | FUNCTION: Component of the cap-binding complex (CBC), which binds co-transcriptionally to the 5' cap of pre-mRNAs and is involved in various processes such as pre-mRNA splicing, translation regulation, nonsense-mediated mRNA decay, RNA-mediated gene silencing (RNAi) by microRNAs (miRNAs) and mRNA export. The CBC complex is involved in mRNA export from the nucleus via its interaction with ALYREF/THOC4/ALY, leading to the recruitment of the mRNA export machinery to the 5' end of mRNA and to mRNA export in a 5' to 3' direction through the nuclear pore. The CBC complex is also involved in mediating U snRNA and intronless mRNAs export from the nucleus. The CBC complex is essential for a pioneer round of mRNA translation, before steady state translation when the CBC complex is replaced by cytoplasmic cap-binding protein eIF4E. The pioneer round of mRNA translation mediated by the CBC complex plays a central role in nonsense-mediated mRNA decay (NMD), NMD only taking place in mRNAs bound to the CBC complex, but not on eIF4E-bound mRNAs. The CBC complex enhances NMD in mRNAs containing at least one exon-junction complex (EJC) via its interaction with UPF1, promoting the interaction between UPF1 and UPF2. The CBC complex is also involved in 'failsafe' NMD, which is independent of the EJC complex, while it does not participate in Staufen-mediated mRNA decay (SMD). During cell proliferation, the CBC complex is also involved in microRNAs (miRNAs) biogenesis via its interaction with SRRT/ARS2, thereby being required for miRNA-mediated RNA interference. The CBC complex also acts as a negative regulator of PARN, thereby acting as an inhibitor of mRNA deadenylation. In the CBC complex, NCBP2/CBP20 recognizes and binds capped RNAs (m7GpppG-capped RNA) but requires NCBP1/CBP80 to stabilize the movement of its N-terminal loop and lock the CBC into a high affinity cap-binding state with the cap structure. The conventional cap-binding complex with NCBP2 binds both small nuclear RNA (snRNA) and messenger (mRNA) and is involved in their export from the nucleus . . FUNCTION: Component of the cap-binding complex (CBC), which binds co-transcriptionally to the 5' cap of pre-mRNAs and is involved in various processes such as pre-mRNA splicing, translation regulation, nonsense-mediated mRNA decay, RNA-mediated gene silencing (RNAi) by microRNAs (miRNAs) and mRNA export. The CBC complex is involved in mRNA export from the nucleus, leading to the recruitment of the mRNA export machinery to the 5' end of mRNA and to mRNA export in a 5' to 3' direction through the nuclear pore. The CBC complex is also involved in mediating U snRNA and intronless mRNAs export from the nucleus. The CBC complex is essential for a pioneer round of mRNA translation, before steady state translation when the CBC complex is replaced by cytoplasmic cap-binding protein eIF4E. The pioneer round of mRNA translation mediated by the CBC complex plays a central role in nonsense-mediated mRNA decay (NMD), NMD only taking place in mRNAs bound to the CBC complex, but not on eIF4E-bound mRNAs. The CBC complex enhances NMD in mRNAs containing at least one exon-junction complex (EJC), promoting the interaction between upf1 and upf2. The CBC complex is also involved in 'failsafe' NMD, which is independent of the EJC complex, while it does not participate in Staufen-mediated mRNA decay (SMD). During cell proliferation, the CBC complex is also involved in microRNAs (miRNAs) biogenesis via its interaction with srrt/ars2, thereby being required for miRNA-mediated RNA interference. The CBC complex also acts as a negative regulator of parn, thereby acting as an inhibitor of mRNA deadenylation. In the CBC complex, ncbp2/cbp20 recognizes and binds capped RNAs (m7GpppG-capped RNA) but requires ncbp1/cbp80 to stabilize the movement of its N-terminal loop and lock the CBC into a high affinity cap-binding state with the cap structure. The conventional cap-binding complex with NCBP2 binds both small nuclear RNA (snRNA) and messenger (mRNA) and is involved in their export from the nucleus. . FUNCTION: Component of the cap-binding complex (CBC), which binds co-transcriptionally to the 5' cap of pre-mRNAs and is involved in various processes such as pre-mRNA splicing, translation regulation, nonsense-mediated mRNA decay, RNA-mediated gene silencing (RNAi) by microRNAs (miRNAs) and mRNA export. The CBC complex is involved in mRNA export from the nucleus, leading to the recruitment of the mRNA export machinery to the 5' end of mRNA and to mRNA export in a 5' to 3' direction through the nuclear pore. The CBC complex is also involved in mediating U snRNA and intronless mRNAs export from the nucleus. The CBC complex is essential for a pioneer round of mRNA translation, before steady state translation when the CBC complex is replaced by cytoplasmic cap-binding protein eIF4E. The pioneer round of mRNA translation mediated by the CBC complex plays a central role in nonsense-mediated mRNA decay (NMD), NMD only taking place in mRNAs bound to the CBC complex, but not on eIF4E-bound mRNAs. The CBC complex enhances NMD in mRNAs containing at least one exon-junction complex (EJC), promoting the interaction between upf1 and upf2. The CBC complex is also involved in 'failsafe' NMD, which is independent of the EJC complex, while it does not participate in Staufen-mediated mRNA decay (SMD). During cell proliferation, the CBC complex is also involved in microRNAs (miRNAs) biogenesis via its interaction with srrt/ars2, thereby being required for miRNA-mediated RNA interference. The CBC complex also acts as a negative regulator of parn, thereby acting as an inhibitor of mRNA deadenylation. In the CBC complex, ncbp2/cbp20 recognizes and binds capped RNAs (m7GpppG-capped RNA) but requires ncbp1/cbp80 to stabilize the movement of its N-terminal loop and lock the CBC into a high affinity cap-binding state with the cap structure. The conventional cap-binding complex with NCBP2 binds both small nuclear RNA (snRNA) and messenger (mRNA) and is involved in their export from the nucleus. . |
Accessions | ENST00000428425.1 C9JKF4 ENST00000447325.5 C9JQX9 ENST00000411704.1 ENST00000422610.5 ENST00000321256.10 [P52298-1] F8WE41 ENST00000427641.2 [P52298-3] ENST00000452404.6 [P52298-2] P52298 F6WVI0 ENST00000455953.1 |